Dec. 19, 2005 —Australia's Therapeutic Goods Administration has approved anecortave acetate 15-mg suspension for depot injection in the treatment of subfoveal choroidal neovascularization due to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback